Three fictional summaries, three different labels
Made-up examples for interpreting outcomes, not clinical advice or actual trial data. None establishes safety or a treatment order.
| Fictional report | What it says | What it does not establish |
|---|---|---|
| A: no cigarettes; still nicotine vaping | Cigarette abstinence within the stated observation window | Stopping vaping or all nicotine |
| B: fewer cigarettes; still smoking and vaping | Reduced cigarette consumption and dual use | Cigarette abstinence or freedom from risk |
| C: no cigarettes or vaping; using a nicotine patch | Neither smoking nor vaping within that window | No nicotine use, or a reason to stop the patch |
What the August 2026 review actually found
Cochrane's living review published 26 August 2026 searched through 1 January 2026 and included 80 completed randomised trials. Its comparison of nicotine e-cigarettes with nicotine replacement therapy—such as patches or gum—used 11 trials with 4,114 participants. More people assigned nicotine e-cigarettes stopped smoking at six months or later: RR 1.61, 95% confidence interval 1.23–2.12, with high-certainty evidence.
The review also found favourable smoking-abstinence results against e-cigarettes without nicotine, with moderate certainty, and against behavioural support alone or no support, with low certainty. These are different comparisons, not a league table of every treatment. RR 1.61 is not a 61-percentage-point gain or your own chance of success. Devices, support and participants varied; the research does not identify a product or nicotine strength for you.
The cigarette question and the nicotine question have different answers
‘Stopped smoking’ can describe someone who no longer uses cigarettes but still vapes nicotine. The updated review separately examines continued e-cigarette use and combinations of smoking and vaping. The main smoking-abstinence result cannot be read as a promise that vaping stops next, or that all nicotine use ends.
Even ‘neither smoking nor vaping’ does not, by itself, mean no nicotine: nicotine replacement products contain nicotine. The fictional table illustrates these labels, not treatment choices or a ranking of people. To understand a reported quit rate, ask which product had to stop, over what period and how the trial checked the outcome. An assessment six months after starting is not automatically six unbroken months without every nicotine product.
High confidence in one benefit is not lifetime safety evidence
Against nicotine replacement therapy, the review judged serious adverse-event proportions probably similar, with moderate certainty limited by imprecision. That is a comparison during the trials, not proof that either exposure has no risk or that decades of vaping have been studied. The certainty for smoking abstinence and the certainty for different safety outcomes must remain separate.
FDA information notes that vaping is not risk-free and that long periods of using both cigarettes and e-cigarettes can retain substantial harm. Cutting down cigarettes while continuing to smoke is not the same outcome as complete cigarette abstinence. The review does not justify starting vaping for someone who does not smoke, and this page does not set out a plan for switching, combining nicotine products or tapering them.
Use the local service context, not an international headline
NHS guidance discusses vaping as a smoking-cessation option while stating that long-term effects are unknown and that no vaping products have been licensed as stop-smoking medicines in the UK. In the United States, CDC also states that no e-cigarette has FDA approval as a smoking-cessation aid. Evidence of a group benefit does not itself grant medicine approval or make either country's service advice universal.
For readers in England, NHS local Stop Smoking Services provide a route to qualified support. Elsewhere, confirm the current local service and rules. Useful questions are whether the goal being discussed is cigarette abstinence or stopping all nicotine, what support and follow-up are available, and who can discuss an existing treatment. No smoking history or health details need to be entered here.
What to keep in mind
Common questions
If I already vape, does this tell me to stop or change products?
No. It explains research outcomes, not what you should use or when to stop. A qualified local professional can discuss smoking, vaping and existing treatment together. This site neither selects a device nor collects personal health information.
Sources
The central claims on this page were checked against the sources below.
- Cochrane Database of Systematic Reviews: Electronic cigarettes for smoking cessation, CD010216.pub11; 26 August2026; search to1 January2026
Sources checked: 2026-10-05
- U.S. Food and Drug Administration: Nicotine, nicotine replacement therapy and the limits of risk comparisons
Sources checked: 2026-10-05
- NHS Better Health: Vaping to quit smoking: smoking cessation, longer-term uncertainty and UK medicine status
Sources checked: 2026-10-05
- Centers for Disease Control and Prevention: E-Cigarettes (Vapes): U.S. cessation-approval status;31 January2025
Sources checked: 2026-10-05
- NHS Better Health: Ready to quit smoking: local Stop Smoking Services in England
Sources checked: 2026-10-05
General education about adult smoking-cessation research, not individual care, legal advice or a product recommendation. No dosing, nicotine-strength, switching or tapering instructions. Pregnancy, younger users and other personal circumstances require qualified local care.